The Shelford Group medical directors have identified artificial intelligence as a strategic priority for shared learning to accelerate adoption and inform national policy.
An AI workshop, hosted by the Shelford Group in April 2019, brought together a number of key individuals and organisations across the AI landscape. It was an opportunity to identify and discuss some of the main issues around the use of AI in healthcare and to identify a number of areas to focus efforts.
Presentations during the workshop included the work at NHSX to develop a toolkit for responsibly applied AI in health and care, patient trust in the use of data by the Health Research Authority, the Health Data Research Hub programme led by Health Data Research UK, two of the new centres of excellence for digital pathology and imaging, and real world examples of AI projects and research development in Shelford Group member trusts.
The project is sponsored by Dr Ashley Shaw – Medical Director at Cambridge University Hospitals NHS Foundation Trust.
Following the workshop the areas in the diagram below were identified as the key opportunities for Shelford Group members to play an active role, with developments currently at the experimental end of the innovation pipeline.
The Shelford Group is also already engaging with, or has identified opportunities to engage with, a number of key stakeholders in the development and implementation of policy and national guidance.
Shelford Group members host two of the five NHS centres of excellence for digital pathology and imaging which were established as part of the UK Government’s Industrial Strategy Challenge Fund, delivered through UK Research and Innovation. These are the London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare and the National Consortium of Intelligent Medical Imaging in Oxford.
All Shelford Group members are part of the National Institute for Health Research’s 20 Biomedical Research Centres (BRCs). The BRCs are collaborations between world-leading universities and NHS organisations that bring together academics and clinicians to translate lab-based scientific breakthroughs into potential new treatments, diagnostics and medical technologies.
Health Data Research UK is the national institute for health data science with a mission to unite the UK’s health data to enable discoveries that improve people’s lives. A key element of this is to create a UK-wide capability to enable the safe and responsible use of health-related data at scale for research and innovation, an initiative funded by the Industrial Strategy Challenge Fund. Shelford Group members are involved in Health Data Research UK’s science, infrastructure and training strategies.